Search results
Earnings call: Aptose Biosciences targets AML treatment with tuspetinib By Investing.com
Investing.com· 6 days agoAptose Biosciences (NASDAQ:APTO) has focused its efforts on developing tuspetinib as part of a novel...
Local Leukemia & Lymphoma Society holds annual fundraiser for blood cancer research
Local 12 Cincinnati· 5 days agoThe local chapter of the Leukemia and Lymphoma Society held its annual fundraiser to raise money for...
Moleculin Abstract Accepted for Poster Presentation at the European Hematology Association (EHA)...
WTRF Wheeling· 5 days agoMoleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses ...
Bio-Path Holdings Inc (BPTH) Q1 2024 Earnings Call Transcript Hi
Guru Focus· 6 days agoNet Loss: $3.2 million for Q1 2024, improved from $5.3 million in Q1 2023.Earnings Per Share (EPS):...
Ryvu Therapeutics First Quarter 2024 Financial Results and Corporate Update
WKBN 27 Youngstown· 7 days agoAs of May 9, 2024, Ryvu's cash position was $59.0M, inclusive of the first tranche of €8M in venture debt from the EIB, obtained in March. This cash position, and other secured funding sources ...
ABC6 'Runs for Brayden' at Rhode Island Half Marathon | ABC6
ABC 6 Providence· 2 days agoEAST PROVIDENCE, R.I. (WLNE) — Members of the ABC6 News staff and more than a thousand others laced...
Anti-diabetic treatment associated with reduced risk of developing blood cancer
Medical Xpress· 4 days ago"Our team was interested in understanding what other effects we see with commonly prescribed ...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 6 days agoPRESS RELEASE AB SCIENCE PRESENTS ITS FINANCIAL INFORMATION AS OF DECEMBER 31, 2023 AND THE KEY EVENTS OF THE PERIOD Clinical development Continuation of the conditional marketing authorisation application procedures with
Bio-Path Holdings Inc (BPTH) Q1 2024 Earnings Call Transcript Highlights: Strategic Advances ...
GuruFocus.com via Yahoo Finance· 6 days agoQ & A Highlights Q: Can you provide an update on the progress of your lead product candidate, prexigebersen, for the treatment of acute myeloid ...
Nicklaus Children’s and FIU Collaborate on Groundbreaking Cancer Research That is Saving Lives
Miami Herald via Yahoo News· 2 days agoDiscover how Nicklaus Children’s Hospital is leading the way in pediatric brain cancer care,...